China Pharma Holdings, Inc. (CPHI) is the 258th largest of 300 Pharmaceuticals companies by market capitalisation, at 31.39 Mn, behind Actuate Therapeutics, Inc. at 31.39 Mn. The table below compares all 300 on 8 financial metrics.
| # | Ticker | Company | match | industry_code | industry_group | industry_group_code | Market Capitalization | P/E | P/S | Enterprise Value |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | JNJ | Johnson & Johnson | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 643.26 Bn | 30.58 | 6.57 | 622.50 Bn |
| 2 | ABBV | AbbVie Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 443.31 Bn | 70.19 | 6.89 | 436.74 Bn |
| 3 | MRK | Merck & Co., Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 364.74 Bn | 115.10 | 5.48 | 357.60 Bn |
| 4 | NVS | Novartis Ag | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 266.46 Bn | 9.25 | 3.88 | 258.77 Bn |
| 5 | PFE | Pfizer Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 158.57 Bn | 36.30 | 2.49 | 146.88 Bn |
| 6 | SNY | Sanofi | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 52.33 Bn | 11.23 | 0.98 | 44.95 Bn |
| 7 | RVMD | Revolution Medicines, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 43.79 Bn | -24.76 | — | 43.79 Bn |
| 8 | INCY | Incyte Corp | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 25.23 Bn | 15.65 | 4.34 | 20.69 Bn |
| 9 | UTHR | UNITED THERAPEUTICS Corp | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 21.67 Bn | 16.53 | 6.87 | 19.01 Bn |
| 10 | NBIX | Neurocrine Biosciences Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 15.65 Bn | 22.19 | 4.64 | 15.26 Bn |
| 11 | JAZZ | Jazz Pharmaceuticals plc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 15.22 Bn | 16.17 | 3.31 | 13.60 Bn |
| 12 | EXEL | Exelixis, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 14.62 Bn | 16.98 | 6.00 | 13.78 Bn |
| 13 | CORT | Corcept Therapeutics Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 12.16 Bn | 224.28 | 14.63 | 11.85 Bn |
| 14 | KYMR | Kymera Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 11.32 Bn | -37.78 | 107.81 | 10.63 Bn |
| 15 | AXSM | Axsome Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 10.89 Bn | -70.84 | 14.02 | 10.57 Bn |
| 16 | CYTK | Cytokinetics Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 9.79 Bn | -13.35 | 144.68 | 8.62 Bn |
| 17 | NUVL | Nuvalent, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 9.75 Bn | -27.07 | — | 9.75 Bn |
| 18 | CRNX | Crinetics Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 8.99 Bn | -17.90 | 213.22 | 8.99 Bn |
| 19 | GPCR | Structure Therapeutics Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 8.96 Bn | -47.63 | — | 8.96 Bn |
| 20 | ALKS | Alkermes plc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 7.58 Bn | 114.56 | 4.54 | 6.92 Bn |
| 21 | TVTX | Travere Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 6.21 Bn | -142.87 | 10.50 | 6.09 Bn |
| 22 | BLTE | Belite Bio, Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 6.15 Bn | 0.08 | — | 6.15 Bn |
| 23 | LQDA | Liquidia Corp | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 6.14 Bn | 44.31 | 13.62 | 5.86 Bn |
| 24 | AMRN | Amarin Corp Plc\Uk | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 5.96 Bn | -219.71 | 32.00 | 5.64 Bn |
| 25 | ACAD | Acadia Pharmaceuticals Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 4.76 Bn | 12.50 | 4.18 | 3.80 Bn |
| 26 | EWTX | Edgewise Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 4.67 Bn | -23.69 | — | 4.67 Bn |
| 27 | DFTX | Definium Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 4.18 Bn | -11.83 | — | 4.18 Bn |
| 28 | INDV | Indivior Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 4.13 Bn | 11.63 | 3.10 | 3.91 Bn |
| 29 | MANE | Veradermics, Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 4.00 Bn | -46.48 | — | 4.00 Bn |
| 30 | CPRX | CATALYST PHARMACEUTICALS, INC. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 3.85 Bn | 17.94 | 6.45 | 3.09 Bn |
| 31 | ELVN | Enliven Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 3.80 Bn | -45.13 | — | 3.80 Bn |
| 32 | TARS | Tarsus Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 3.59 Bn | -76.58 | 5.93 | 3.14 Bn |
| 33 | OGN | Organon & Co. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 3.59 Bn | 17.20 | 0.59 | 2.46 Bn |
| 34 | NAMS | NewAmsterdam Pharma Co N.V. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.81 Bn | -10.83 | 394.49 | 2.81 Bn |
| 35 | TAK | Takeda Pharmaceutical Co Ltd | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.61 Bn | 4.54 | 0.06 | -3.19 Bn |
| 36 | TRVI | Trevi Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.60 Bn | -61.67 | — | 2.60 Bn |
| 37 | MLYS | Mineralys Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.59 Bn | -7.41 | — | 2.59 Bn |
| 38 | BEIGF | BeOne Medicines Ltd. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.48 Bn | 3.74 | 0.40 | -2.62 Bn |
| 39 | SUPN | Supernus Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.44 Bn | -28.71 | 3.10 | 2.07 Bn |
| 40 | HRMY | Harmony Biosciences Holdings, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.41 Bn | 13.50 | 2.51 | 1.60 Bn |
| 41 | NUVB | Nuvation Bio Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.28 Bn | -21.11 | 13.44 | 2.28 Bn |
| 42 | PVLA | Palvella Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.18 Bn | -41.21 | — | 1.87 Bn |
| 43 | AUPH | Aurinia Pharmaceuticals Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.11 Bn | 6.70 | 6.76 | 1.66 Bn |
| 44 | ETON | Eton Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.63 Bn | 170.39 | 16.23 | 1.60 Bn |
| 45 | INVA | Innoviva, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.55 Bn | 7.91 | 3.01 | 0.97 Bn |
| 46 | LBRX | Lb Pharmaceuticals Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.43 Bn | -23.70 | — | 1.43 Bn |
| 47 | HROW | Harrow, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.41 Bn | -42.04 | 5.10 | 1.32 Bn |
| 48 | XERS | Xeris Biopharma Holdings, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.33 Bn | -77.52 | 3.97 | 1.21 Bn |
| 49 | OPK | Opko Health, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.16 Bn | -30.70 | 1.98 | 0.86 Bn |
| 50 | OLMA | Olema Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.09 Bn | -5.32 | — | 1.09 Bn |
| 51 | KURA | Kura Oncology, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.08 Bn | -4.53 | 13.95 | 1.08 Bn |
| 52 | PCRX | Pacira BioSciences, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.02 Bn | 69.58 | 1.37 | 0.77 Bn |
| 53 | LXRX | Lexicon Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.94 Bn | -15.00 | 22.74 | 0.75 Bn |
| 54 | DSGN | Design Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.93 Bn | -11.54 | — | 0.73 Bn |
| 55 | SGP | SpyGlass Pharma, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.91 Bn | -48.72 | — | 0.91 Bn |
| 56 | VSTM | Verastem, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.80 Bn | -6.91 | 9.10 | 0.66 Bn |
| 57 | COLL | Collegium Pharmaceutical, Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.75 Bn | 15.72 | 0.93 | 0.60 Bn |
| 58 | PHAT | Phathom Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.73 Bn | -7.42 | 3.04 | 0.54 Bn |
| 59 | ZVRA | Zevra Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.71 Bn | 12.24 | 5.24 | 0.49 Bn |
| 60 | GYRE | Gyre Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.70 Bn | -38.15 | 5.90 | 0.65 Bn |
| 61 | IVEVF | Inventiva S.A. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.69 Bn | 7.19 | 132.94 | 0.69 Bn |
| 62 | AQST | Aquestive Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.64 Bn | -8.19 | 11.84 | 0.54 Bn |
| 63 | CRMD | CorMedix Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.64 Bn | 5.07 | 1.70 | 0.38 Bn |
| 64 | MPLT | MapLight Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.63 Bn | -3.10 | — | 0.63 Bn |
| 65 | EOLS | Evolus, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.56 Bn | -16.41 | 1.78 | 0.52 Bn |
| 66 | NVCT | Nuvectis Pharma, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.54 Bn | -17.80 | — | 0.54 Bn |
| 67 | OVID | Ovid Therapeutics Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.53 Bn | -15.37 | 334.91 | 0.41 Bn |
| 68 | SPRY | ARS Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.52 Bn | -2.36 | 4.46 | 0.38 Bn |
| 69 | XFOR | X4 Pharmaceuticals, Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.45 Bn | -4.99 | 28.37 | 0.25 Bn |
| 70 | PALI | Palisade Bio, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.44 Bn | -12.43 | 877.24 | 0.31 Bn |
| 71 | IKT | Inhibikase Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.42 Bn | -6.43 | — | 0.26 Bn |
| 72 | VTVT | vTv Therapeutics Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.42 Bn | -87.86 | 11.34 | 0.42 Bn |
| 73 | TTRX | Turn Therapeutics Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.41 Bn | -52.78 | — | 0.41 Bn |
| 74 | SION | Sionna Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.34 Bn | -3.47 | — | 0.34 Bn |
| 75 | ACHV | Achieve Life Sciences, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.33 Bn | — | — | 0.33 Bn |
| 76 | VNDA | Vanda Pharmaceuticals Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.32 Bn | -1.15 | 1.47 | 0.15 Bn |
| 77 | IMRX | Immuneering Corp | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.30 Bn | -5.02 | — | 0.30 Bn |
| 78 | EBS | Emergent BioSolutions Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.29 Bn | -1.67 | 0.38 | 0.15 Bn |
| 79 | FULC | Fulcrum Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.29 Bn | -3.29 | — | 0.29 Bn |
| 80 | ZNTL | Zentalis Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.27 Bn | -1.94 | — | 0.27 Bn |
| 81 | AKBA | Akebia Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.26 Bn | -8.70 | 1.18 | 0.10 Bn |
| 82 | CELG-RI | Bristol Myers Squibb Co | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.23 Bn | 0.03 | 0.00 | -10.83 Bn |
| 83 | SIGA | Siga Technologies Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.22 Bn | — | — | 0.07 Bn |
| 84 | TNXP | Tonix Pharmaceuticals Holding Corp. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.21 Bn | -1.33 | 7.32 | 0.21 Bn |
| 85 | DERM | Journey Medical Corp | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.20 Bn | -55.91 | 3.00 | 0.18 Bn |
| 86 | CRDL | Cardiol Therapeutics Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.20 Bn | -7.59 | — | 0.20 Bn |
| 87 | MCUJF | Medicure Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.20 Bn | -38.89 | 8.50 | 0.20 Bn |
| 88 | ACOG | Alpha Cognition Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.20 Bn | -7.17 | 14.71 | 0.16 Bn |
| 89 | SLGL | Sol-Gel Technologies Ltd. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.19 Bn | -18.55 | 108.38 | 0.15 Bn |
| 90 | NERV | Minerva Neurosciences, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.19 Bn | -29.09 | — | 0.19 Bn |
| 91 | LONA | LeonaBio, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.17 Bn | -1.42 | — | 0.12 Bn |
| 92 | MENS | Jyong Biotech Ltd. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.16 Bn | -46.69 | — | 0.16 Bn |
| 93 | LENZ | LENZ Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.15 Bn | -1.19 | 7.19 | 0.15 Bn |
| 94 | BMEA | Biomea Fusion, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.13 Bn | -2.33 | — | 0.13 Bn |
| 95 | VANI | Vivani Medical, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.11 Bn | -4.22 | — | 0.10 Bn |
| 96 | VRCA | Verrica Pharmaceuticals Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.11 Bn | -3.48 | 3.60 | 0.10 Bn |
| 97 | AARD | Aardvark Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.11 Bn | -1.55 | — | 0.03 Bn |
| 98 | TENX | Tenax Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.10 Bn | -1.49 | — | 0.10 Bn |
| 99 | CPIX | Cumberland Pharmaceuticals Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.10 Bn | -8.86 | 3.05 | 0.09 Bn |
| 100 | CGTX | Cognition Therapeutics Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.09 Bn | -2.47 | — | 0.09 Bn |
| 101 | NTHI | Neonc Technologies Holdings, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.09 Bn | -1.99 | — | 0.09 Bn |
| 102 | MNOV | Medicinova Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.09 Bn | -7.67 | 100.93 | 0.09 Bn |
| 103 | PTHS | Pelthos Therapeutics Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.08 Bn | -0.76 | 1.57 | 0.06 Bn |
| 104 | RGC | Regencell Bioscience Holdings Ltd | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.08 Bn | — | — | 0.07 Bn |
| 105 | PMVP | PMV Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.07 Bn | -1.20 | — | -0.01 Bn |
| 106 | PLRX | Pliant Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.07 Bn | -0.77 | — | 0.07 Bn |
| 107 | BOLD | Boundless Bio, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.06 Bn | -1.00 | — | 0.06 Bn |
| 108 | VERU | Veru Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.06 Bn | 115.53 | — | 0.03 Bn |
| 109 | GOSS | Gossamer Bio, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.05 Bn | -0.30 | 0.96 | -0.01 Bn |
| 110 | KPTI | Karyopharm Therapeutics Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.05 Bn | -0.25 | 0.33 | -0.02 Bn |
| 111 | ANVS | Annovis Bio, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.05 Bn | -0.95 | — | 0.05 Bn |
| 112 | CLNN | Clene Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.05 Bn | -1.36 | 217.73 | 0.05 Bn |
| 113 | APRE | Aprea Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | -3.41 | — | 0.04 Bn |
| 114 | IXHL | Incannex Healthcare Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | -0.84 | — | 0.04 Bn |
| 115 | GRCE | Grace Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | -1.85 | — | 0.04 Bn |
| 116 | SCLX | Scilex Holding Co | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | -0.08 | 1.13 | -0.08 Bn |
| 117 | UG | United Guardian Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | 14.34 | 2.90 | 0.02 Bn |
| 118 | ACTU | Actuate Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -1.51 | — | 0.03 Bn |
| 119 | CPHI | China Pharma Holdings, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -7.01 | 8.02 | 0.03 Bn |
| 120 | NSRX | Nasus Pharma Ltd | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -5.64 | — | 0.03 Bn |
| 121 | CRVO | CervoMed Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -0.85 | 77.46 | 0.03 Bn |
| 122 | YARW | Yarrow Bioscience, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -1.20 | 50.30 | 0.00 Bn |
| 123 | BYSI | BeyondSpring Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -2.97 | — | 0.03 Bn |
| 124 | TXMD | TherapeuticsMD, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -132.69 | 7.51 | 0.02 Bn |
| 125 | AYTU | Aytu Biopharma, Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -0.73 | 0.40 | 0.00 Bn |
| 126 | ATOS | Atossa Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -0.72 | — | 0.02 Bn |
| 127 | ALLR | Allarity Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -1.67 | 808.26 | 0.02 Bn |
| 128 | BFRI | Biofrontera Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -4.28 | 0.45 | 0.02 Bn |
| 129 | MIRA | Mira Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -0.56 | — | 0.01 Bn |
| 130 | TVRD | Tvardi Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -0.67 | — | 0.02 Bn |
| 131 | KPRX | Kiora Pharmaceuticals Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -1.41 | — | 0.02 Bn |
| 132 | CTXR | Citius Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -0.33 | 2.17 | 0.02 Bn |
| 133 | ANEB | Anebulo Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -1.64 | — | 0.01 Bn |
| 134 | INTI | Inhibitor Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -3.67 | — | 0.01 Bn |
| 135 | CALC | CalciMedica, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -0.38 | -9.36 | -0.01 Bn |
| 136 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -0.74 | — | 0.01 Bn |
| 137 | ADXN | Addex Therapeutics Ltd. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | 0.05 | — | 0.01 Bn |
| 138 | ACXP | Acurx Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -0.81 | — | 0.01 Bn |
| 139 | CURX | Curanex Pharmaceuticals Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -0.80 | — | 0.00 Bn |
| 140 | TRAW | Traws Pharma, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -0.35 | — | 0.00 Bn |
| 141 | PCSA | Processa Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -0.41 | — | 0.01 Bn |
| 142 | PULM | Pulmatrix, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -1.32 | — | 0.01 Bn |
| 143 | TCRT | Alaunos Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.93 | 1,256.38 | 0.00 Bn |
| 144 | BICX | BioCorRx Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -1.64 | 6.70 | 0.00 Bn |
| 145 | CVKD | Cadrenal Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.30 | — | 0.00 Bn |
| 146 | CASIF | CASI Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.02 | 0.12 | 0.00 Bn |
| 147 | OGEN | Oragenics Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.22 | — | 0.00 Bn |
| 148 | CANF | Can-Fite BioPharma Ltd. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.24 | 5.93 | 0.00 Bn |
| 149 | UPC | Universe Pharmaceuticals INC | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | — | — | -1,490.23 Bn |
| 150 | ENSC | Ensysce Biosciences, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | — | — | 0.00 Bn |
| 151 | MTNB | Matinas BioPharma Holdings, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.16 | — | 0.00 Bn |
| 152 | SKVI | Skinvisible, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -1.05 | 54.04 | 0.00 Bn |
| 153 | SPRC | SciSparc Ltd. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.05 | 0.76 | 0.00 Bn |
| 154 | GLMD | Galmed Pharmaceuticals Ltd. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | — | — | 0.00 Bn |
| 155 | NCEL | NewcelX Ltd. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.06 | — | 0.00 Bn |
| 156 | CDT | CDT Equity Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.01 | — | 0.00 Bn |
| 157 | JAGX | Jaguar Health, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.01 | 0.01 | -0.01 Bn |
| 158 | GCAN | Trafalgar International, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -1.77 | — | 0.00 Bn |
| 159 | CINGW | Cingulate Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | 0.00 | — | 0.00 Bn |
| 160 | SXTC | China SXT Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | 0.00 | 0.03 | -0.03 Bn |
| 161 | CMND | Clearmind Medicine Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | 0.00 | — | -0.01 Bn |
| 162 | PG | PROCTER & GAMBLE Co | secondary | S-10 | Household and Personal Products | SG-05 | 332.67 Bn | 20.61 | 3.82 | 322.72 Bn |
| 163 | GILD | Gilead Sciences, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 180.92 Bn | -62.49 | 5.94 | 177.74 Bn |
| 164 | VRTX | Vertex Pharmaceuticals Inc / Ma | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 132.16 Bn | 30.00 | 10.50 | 124.30 Bn |
| 165 | ISRG | Intuitive Surgical Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 125.02 Bn | 39.59 | 11.33 | 119.81 Bn |
| 166 | MDT | Medtronic plc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 117.84 Bn | 22.36 | 3.14 | 109.02 Bn |
| 167 | MCK | Mckesson Corp | secondary | H-19 | Healthcare Payers and Distributors | HG-05 | 106.22 Bn | 20.04 | 0.26 | 101.06 Bn |
| 168 | CAH | Cardinal Health Inc | secondary | H-19 | Healthcare Payers and Distributors | HG-05 | 56.55 Bn | 33.17 | 0.22 | 51.69 Bn |
| 169 | BDX | Becton Dickinson & Co | secondary | H-07 | Medical Devices and Diagnostics | HG-02 | 49.48 Bn | 52.52 | 2.13 | 48.62 Bn |
| 170 | TEVA | Teva Pharmaceutical Industries Ltd | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 42.84 Bn | 61.56 | 2.47 | 39.19 Bn |
| 171 | ADM | Archer-Daniels-Midland Co | secondary | S-07 | Agribusiness | SG-03 | 41.79 Bn | 23.49 | 0.51 | 32.22 Bn |
| 172 | KVUE | Kenvue Inc. | secondary | S-11 | Household and Personal Products | SG-05 | 34.17 Bn | 20.61 | 2.22 | 33.06 Bn |
| 173 | ALC | Alcon Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 33.70 Bn | 52.41 | 3.13 | 32.24 Bn |
| 174 | KMB | Kimberly Clark Corp | secondary | S-11 | Household and Personal Products | SG-05 | 32.86 Bn | 18.50 | 1.98 | 31.91 Bn |
| 175 | DXCM | Dexcom Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 32.06 Bn | 32.07 | 6.45 | 30.11 Bn |
| 176 | ROIV | Roivant Sciences Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 30.05 Bn | -20.25 | 2,751.33 | 30.05 Bn |
| 177 | GEHC | GE HealthCare Technologies Inc. | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 29.54 Bn | 14.41 | 1.39 | 27.44 Bn |
| 178 | MDLN | Medline Inc. | secondary | H-07 | Medical Devices and Diagnostics | HG-02 | 29.24 Bn | 28.30 | 1.02 | 26.56 Bn |
| 179 | INSM | INSMED Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 27.99 Bn | -31.97 | 24.60 | 26.83 Bn |
| 180 | WST | West Pharmaceutical Services Inc | secondary | H-07 | Medical Devices and Diagnostics | HG-02 | 23.94 Bn | 43.58 | 7.20 | 23.51 Bn |
| 181 | CHD | Church & Dwight Co Inc /De/ | secondary | S-10 | Household and Personal Products | SG-05 | 22.57 Bn | 30.30 | 3.62 | 22.31 Bn |
| 182 | STE | STERIS plc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 21.02 Bn | 26.01 | 3.48 | 20.54 Bn |
| 183 | VTRS | Viatris Inc | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 19.13 Bn | -46.58 | 1.30 | 18.24 Bn |
| 184 | NDSN | Nordson Corp | secondary | I-04 | Machinery | IG-02 | 17.47 Bn | 31.47 | 5.86 | 17.36 Bn |
| 185 | SOLV | Solventum Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 15.55 Bn | 10.84 | 1.87 | 15.15 Bn |
| 186 | BWXT | BWX Technologies, Inc. | secondary | I-39 | Clean Energy Equipment | IG-10 | 14.38 Bn | 40.38 | 4.09 | 13.77 Bn |
| 187 | BAX | Baxter International Inc | secondary | H-07 | Medical Devices and Diagnostics | HG-02 | 12.66 Bn | 550.61 | 1.14 | 10.51 Bn |
| 188 | COO | Cooper Companies, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 12.34 Bn | 52.34 | 2.92 | 12.20 Bn |
| 189 | CLX | Clorox Co /De/ | secondary | S-10 | Household and Personal Products | SG-05 | 10.92 Bn | 18.17 | 1.62 | 10.78 Bn |
| 190 | GKOS | GLAUKOS Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 10.58 Bn | -67.15 | 17.26 | 10.46 Bn |
| 191 | PRAX | Praxis Precision Medicines, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 10.05 Bn | -26.35 | — | 9.29 Bn |
| 192 | CHWY | Chewy, Inc. | secondary | S-04 | Branded Foods | SG-02 | 8.46 Bn | 33.13 | 0.66 | 7.94 Bn |
| 193 | ATR | Aptargroup, Inc. | secondary | I-04 | Machinery | IG-02 | 7.76 Bn | 21.38 | 1.97 | 7.56 Bn |
| 194 | CELH | Celsius Holdings, Inc. | secondary | S-03 | Beverages | SG-01 | 7.05 Bn | 117.53 | 2.31 | 6.42 Bn |
| 195 | MMED | MiniMed Group, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 6.37 Bn | -20.43 | 2.00 | 6.17 Bn |
| 196 | BLCO | Bausch & Lomb Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 6.33 Bn | -38.86 | 1.19 | 5.96 Bn |
| 197 | BLRX | BioLineRx Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 6.31 Bn | -704.68 | 4,533.84 | 6.31 Bn |
| 198 | NOVT | Novanta Inc | secondary | I-04 | Machinery | IG-02 | 5.98 Bn | 113.00 | 5.81 | 5.26 Bn |
| 199 | TFX | Teleflex Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 5.93 Bn | -5.27 | 2.63 | 5.63 Bn |
| 200 | STVN | Stevanato Group S.p.A. | secondary | H-07 | Medical Devices and Diagnostics | HG-02 | 5.51 Bn | 35.10 | 3.86 | 5.40 Bn |
| 201 | AMRX | Amneal Pharmaceuticals, Inc. | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 5.51 Bn | 25.57 | 1.77 | 5.38 Bn |
| 202 | MMSI | Merit Medical Systems Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 5.19 Bn | 35.68 | 3.29 | 4.74 Bn |
| 203 | ERAS | Erasca, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 4.89 Bn | -17.03 | — | 4.89 Bn |
| 204 | FMCQF | Fresenius Medical Care AG | secondary | H-14 | Healthcare Providers | HG-04 | 4.79 Bn | 4.57 | 0.17 | 4.09 Bn |
| 205 | HAE | Haemonetics Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 4.68 Bn | 48.56 | 3.46 | 4.45 Bn |
| 206 | LIVN | LivaNova PLC | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 4.34 Bn | 22.87 | 2.95 | 3.82 Bn |
| 207 | DNLI | Denali Therapeutics Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 4.06 Bn | -7.94 | 1,126.80 | 4.06 Bn |
| 208 | ICUI | Icu Medical Inc/De | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 4.03 Bn | 120.71 | 1.87 | 3.73 Bn |
| 209 | BBWI | Bath & Body Works, Inc. | secondary | S-11 | Household and Personal Products | SG-05 | 3.85 Bn | 5.81 | 0.52 | 3.05 Bn |
| 210 | PLSE | Pulse Biosciences, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 3.67 Bn | -45.48 | 4,678.06 | 3.67 Bn |
| 211 | RCUS | Arcus Biosciences, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 3.59 Bn | -7.79 | 30.64 | 2.88 Bn |
| 212 | IPAR | Interparfums Inc | secondary | S-12 | Household and Personal Products | SG-05 | 3.57 Bn | 17.39 | 2.38 | 3.36 Bn |
| 213 | TMDX | TransMedics Group, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 2.98 Bn | 17.41 | 4.46 | 2.51 Bn |
| 214 | IMNM | Immunome Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.96 Bn | -10.96 | 593.06 | 2.44 Bn |
| 215 | NRIX | Nurix Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.93 Bn | -8.57 | 79.61 | 2.48 Bn |
| 216 | ZLAB | Zai Lab Ltd | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.80 Bn | -14.90 | 6.24 | 2.10 Bn |
| 217 | WDFC | Wd 40 Co | secondary | S-10 | Household and Personal Products | SG-05 | 2.69 Bn | 30.13 | 3.98 | 2.63 Bn |
| 218 | CURLF | Curaleaf Holdings, Inc. | secondary | S-09 | Tobacco and Cannabis | SG-04 | 2.66 Bn | -22.42 | 2.03 | 2.56 Bn |
| 219 | SLS | SELLAS Life Sciences Group, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.64 Bn | -81.36 | — | 2.64 Bn |
| 220 | ATRC | AtriCure, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 2.58 Bn | 244.35 | 4.53 | 2.41 Bn |
| 221 | BHC | Bausch Health Companies Inc. | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 2.30 Bn | -2.11 | 0.21 | 0.46 Bn |
| 222 | BCRX | Biocryst Pharmaceuticals Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.29 Bn | -5.95 | 4.28 | 1.94 Bn |
| 223 | BHVN | Biohaven Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.27 Bn | -3.87 | — | 2.00 Bn |
| 224 | UFPT | Ufp Technologies Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 2.16 Bn | 29.86 | 3.42 | 2.15 Bn |
| 225 | XRAY | DENTSPLY SIRONA Inc. | secondary | H-09 | Medical Devices and Diagnostics | HG-02 | 2.13 Bn | -3.90 | 0.59 | 1.89 Bn |
| 226 | ZBIO | Zenas BioPharma, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.03 Bn | -4.89 | 2,033.16 | 2.03 Bn |
| 227 | PRGO | PERRIGO Co plc | secondary | S-11 | Household and Personal Products | SG-05 | 1.99 Bn | -1.15 | 0.48 | 1.59 Bn |
| 228 | SPB | Spectrum Brands Holdings, Inc. | secondary | S-04 | Branded Foods | SG-02 | 1.99 Bn | 23.49 | 0.69 | 1.73 Bn |
| 229 | EPAC | Enerpac Tool Group Corp | secondary | I-08 | Machinery | IG-02 | 1.86 Bn | 19.97 | 2.94 | 1.75 Bn |
| 230 | LMAT | Lemaitre Vascular Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.81 Bn | 27.63 | 6.91 | 1.44 Bn |
| 231 | AAPG | Ascentage Pharma Group International | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.54 Bn | -9.11 | 20.12 | 1.26 Bn |
| 232 | ANIP | Ani Pharmaceuticals Inc | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 1.49 Bn | 13.80 | 1.52 | 1.13 Bn |
| 233 | RARE | Ultragenyx Pharmaceutical Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.47 Bn | -3.17 | 2.04 | 1.17 Bn |
| 234 | AVBP | ArriVent BioPharma, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.42 Bn | -8.67 | — | 1.42 Bn |
| 235 | CNMD | CONMED Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.42 Bn | 25.07 | 1.03 | 1.38 Bn |
| 236 | OMER | Omeros Corp | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.40 Bn | 82.16 | 36.50 | 1.40 Bn |
| 237 | NMAX | Newsmax Inc. | secondary | C-05 | Advertising and Media | CG-02 | 1.37 Bn | -17.21 | 8.92 | 1.32 Bn |
| 238 | TNDM | Tandem Diabetes Care Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.32 Bn | -20.85 | 1.27 | 0.86 Bn |
| 239 | HLF | Herbalife Ltd. | secondary | S-11 | Household and Personal Products | SG-05 | 1.32 Bn | 5.18 | 0.25 | 0.95 Bn |
| 240 | IART | Integra Lifesciences Holdings Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.25 Bn | -172.77 | 0.76 | 0.98 Bn |
| 241 | EPC | EDGEWELL PERSONAL CARE Co | secondary | S-11 | Household and Personal Products | SG-05 | 1.24 Bn | -17.89 | 0.55 | 0.84 Bn |
| 242 | CRVS | Corvus Pharmaceuticals, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.23 Bn | -25.77 | — | 1.02 Bn |
| 243 | AORT | Artivion, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.22 Bn | -386.79 | 2.60 | 1.15 Bn |
| 244 | PRCT | PROCEPT BioRobotics Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.18 Bn | -10.30 | 3.50 | 0.90 Bn |
| 245 | AVNS | Avanos Medical, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.17 Bn | -15.62 | 1.63 | 1.10 Bn |
| 246 | IRMD | Iradimed Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.07 Bn | 46.40 | 12.35 | 1.01 Bn |
| 247 | RAJAF | TFA Therapeutics, Inc. | secondary | S-11 | Household and Personal Products | SG-05 | 1.02 Bn | — | 819.11 | 1.02 Bn |
| 248 | MNPR | Monopar Therapeutics | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.97 Bn | -70.03 | — | 0.92 Bn |
| 249 | INMD | InMode Ltd. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.96 Bn | 11.11 | 2.55 | 0.47 Bn |
| 250 | ODD | Oddity Tech Ltd | secondary | S-12 | Household and Personal Products | SG-05 | 0.93 Bn | 12.71 | 1.26 | 0.63 Bn |
| 251 | CBLL | Ceribell, Inc. | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.93 Bn | -14.07 | 9.11 | 0.80 Bn |
| 252 | BVS | Bioventus Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.92 Bn | 15.03 | 1.59 | 0.89 Bn |
| 253 | SIBN | SI-BONE, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.82 Bn | -56.12 | 3.83 | 0.67 Bn |
| 254 | ACRS | Aclaris Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.79 Bn | -9.89 | 95.78 | 0.79 Bn |
| 255 | BBNX | Beta Bionics, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.79 Bn | -10.78 | 6.61 | 0.61 Bn |
| 256 | AHCO | AdaptHealth Corp. | secondary | H-15 | Healthcare Providers | HG-04 | 0.78 Bn | -3.48 | 0.24 | 0.73 Bn |
| 257 | MLAB | Mesa Laboratories Inc /Co/ | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 0.70 Bn | 199.22 | 2.81 | 0.67 Bn |
| 258 | SSII | SS Innovations International, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.65 Bn | -42.42 | 12.41 | 0.63 Bn |
| 259 | ANGO | Angiodynamics Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.64 Bn | -17.31 | 1.99 | 0.58 Bn |
| 260 | HELE | Helen Of Troy Ltd | secondary | D-06 | Household Durables | DG-02 | 0.63 Bn | -1.54 | 0.35 | 0.61 Bn |
| 261 | EVOH | EvoAir Holdings Inc. | secondary | I-14 | Construction Products | IG-03 | 0.63 Bn | -56.89 | 1,861.02 | 0.62 Bn |
| 262 | HNST | Honest Company, Inc. | secondary | S-11 | Household and Personal Products | SG-05 | 0.60 Bn | -49.65 | 1.77 | 0.50 Bn |
| 263 | OCS | Oculis Holding AG | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.60 Bn | -340,055.90 | — | 0.60 Bn |
| 264 | BWMX | Betterware De Mexico, S.A.P.I. De C.V | secondary | S-12 | Household and Personal Products | SG-05 | 0.58 Bn | 10.21 | 0.57 | 0.55 Bn |
| 265 | DCTH | Delcath Systems, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.58 Bn | 1,165.03 | 6.03 | 0.48 Bn |
| 266 | IRD | Opus Genetics, Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.54 Bn | -5.57 | 54.88 | 0.45 Bn |
| 267 | SENS | Senseonics Holdings, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.51 Bn | -4.64 | 10.46 | 0.27 Bn |
| 268 | CERS | Cerus Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.50 Bn | -27.93 | 2.02 | 0.45 Bn |
| 269 | PRLD | Prelude Therapeutics Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.50 Bn | -7.41 | 22.27 | 0.22 Bn |
| 270 | ANL | Adlai Nortye Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.47 Bn | -10.27 | 78.36 | 0.23 Bn |
| 271 | EVMN | Evommune, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.39 Bn | -4.14 | 39.23 | 0.19 Bn |
| 272 | OBIO | Orchestra BioMed Holdings, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.35 Bn | -5.83 | 10.86 | 0.15 Bn |
| 273 | PRE | Prenetics Global Ltd | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.34 Bn | -7.19 | 2.44 | 0.28 Bn |
| 274 | VMD | Viemed Healthcare, Inc. | secondary | H-15 | Healthcare Providers | HG-04 | 0.33 Bn | 22.31 | 1.11 | 0.32 Bn |
| 275 | SWKHL | SWK Holdings Corp | secondary | F-06 | Lending and Credit | FG-02 | 0.31 Bn | -333.28 | 7.49 | 0.27 Bn |
| 276 | SMTI | Sanara MedTech Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.30 Bn | -9.84 | 2.10 | 0.30 Bn |
| 277 | TMCI | Treace Medical Concepts, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.29 Bn | -5.13 | 1.44 | 0.25 Bn |
| 278 | USNA | Usana Health Sciences Inc | secondary | S-11 | Household and Personal Products | SG-05 | 0.28 Bn | -9.51 | 0.30 | 0.11 Bn |
| 279 | BFNH | Bioforce Nanosciences Holdings, Inc. | secondary | S-11 | Household and Personal Products | SG-05 | 0.26 Bn | -2,541.40 | — | 0.26 Bn |
| 280 | PROF | Profound Medical Corp. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.25 Bn | 3.71 | 12.93 | 0.21 Bn |
| 281 | INFU | InfuSystem Holdings, Inc | secondary | H-14 | Healthcare Providers | HG-04 | 0.24 Bn | 28.60 | 1.70 | 0.24 Bn |
| 282 | NATR | Natures Sunshine Products Inc | secondary | S-11 | Household and Personal Products | SG-05 | 0.24 Bn | 13.00 | 0.49 | 0.16 Bn |
| 283 | NAGE | Niagen Bioscience, Inc. | secondary | S-11 | Household and Personal Products | SG-05 | 0.24 Bn | 15.13 | 1.87 | 0.18 Bn |
| 284 | NUS | Nu Skin Enterprises, Inc. | secondary | S-12 | Household and Personal Products | SG-05 | 0.23 Bn | -1.06 | 0.17 | 0.04 Bn |
| 285 | ACU | Acme United Corp | secondary | H-07 | Medical Devices and Diagnostics | HG-02 | 0.23 Bn | 23.81 | 1.10 | 0.23 Bn |
| 286 | ELMD | Electromed, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.22 Bn | 19.73 | 3.02 | 0.20 Bn |
| 287 | PTNM | Pitanium Ltd | secondary | S-12 | Household and Personal Products | SG-05 | 0.21 Bn | -63.51 | 24.53 | -2.70 Bn |
| 288 | FTH | Faeth Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.21 Bn | -1.05 | — | 0.21 Bn |
| 289 | FOCL | Edap Tms Sa | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.16 Bn | -4.97 | 2.29 | 0.14 Bn |
| 290 | WALD | Waldencast plc | secondary | S-12 | Household and Personal Products | SG-05 | 0.16 Bn | -1.84 | 0.67 | 0.12 Bn |
| 291 | TNYA | Tenaya Therapeutics, Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.14 Bn | -1.40 | 107.84 | 0.14 Bn |
| 292 | NWOEF | New Oriental Education & Technology Group Inc. | secondary | D-28 | Consumer Services | DG-09 | 0.14 Bn | 0.17 | 0.03 | -2.26 Bn |
| 293 | IFRX | InflaRx N.V. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.14 Bn | 0.00 | 1,788.24 | -0.04 Bn |
| 294 | SPRB | Spruce Biosciences, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.14 Bn | -2.80 | — | 0.14 Bn |
| 295 | MED | Medifast Inc | secondary | S-11 | Household and Personal Products | SG-05 | 0.13 Bn | -5.26 | 0.43 | -0.04 Bn |
| 296 | APYX | Apyx Medical Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.13 Bn | -15.44 | 2.28 | 0.11 Bn |
| 297 | STXS | Stereotaxis, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.13 Bn | -5.64 | 4.15 | 0.11 Bn |
| 298 | MBOT | Microbot Medical Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.10 Bn | -6.88 | 83.84 | 0.10 Bn |
| 299 | SKIN | SkinHealth Systems Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.09 Bn | -3.15 | 0.31 | -0.12 Bn |
| 300 | PYPD | PolyPid Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.09 Bn | 2.72 | — | 0.08 Bn |